Not applicableNot Yet RecruitingNCT07536724
What this trial is testing
First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation
Who this might be right for
Symptomatic Tricuspid Regurgitation (TR) Graded as Severe or Greater
Medira GmbH 10